MicroStockHub/E+ via Getty Images Bitcoin (BTC-USD) is set to fall 5.2% on a weekly basis, as the robust demand buoyed by the creation of spot BTC ETFs earlier in the year has cooled. “Bitcoin is facing some short-term headwinds as the market fears sell pressure from governments and Mt. GoxContinue Reading
Jun. 28, 2024 7:18 AM ETNIKE, Inc. (NKE) Stock, FL Stock, UA Stock, ONON StockXLY, DECK, CROX, DKS, SKX, ADDYY, UAA, LULU, NBCC, LUXXBy: Clark Schultz, SA News Editor da-kuk The footwear sector is reeling after Nike’s (NYSE:NKE) earnings report raised concerns about global demand. Nike (NKE) warned that salesContinue Reading
Traders and investors watched Wall Street’s major market averages conclude in a more muted fashion on Thursday after markets received a slew of economic data in the early part of the day. The tech focused Nasdaq Composite (COMP.IND) ended higher by 0.3% and closed out at 17,858.68. At the sameContinue Reading
Wall Street on Thursday continued to struggle for momentum, as a slide in Walgreens Boots Alliance (WBA) and Micron Technology (MU) capped gains. Meanwhile, U.S. Treasurys rebounded after a plethora of economic data lent support to a scenario where the Federal Reserve can start cutting interest rates. The benchmark S&PContinue Reading
Petrovich9/iStock via Getty Images AeroVironment’s (NASDAQ:AVAV) stock fell 6.6% in extended trading Wednesday after the maker of military drones and unmanned vehicles reported a steep decline in earnings while still beating the average estimate among Wall Street analysts. Earnings adjusted for one-item items fell 57% from a year earlier toContinue Reading
Oragenics (NYSE:OGEN) said on Monday it was proposing to offer and sell shares of its common stock (or pre-funded warrants) in a public offering. Shares of OGEN fell 6.02% in extended trading. The company said that all the securities to be sold in the offering are to be offered by Oragenics. OGEN plans to use the offering to fund theContinue Reading
jetcityimage/iStock Editorial via Getty Images Respiratory device makers ResMed (NYSE:RMD), and Philips (NYSE:PHG) traded lower on Friday after Eli Lilly (NYSE:LLY) said an FDA decision on a potential label expansion for its weight loss therapy tirzepatide against obstructive sleep apnea (OSA) is expected later this year. The announcement hurt theContinue Reading
